EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study

Ai Ling Oh iD, Mohd Makmor-Bakry, Farida Islahudin iD, Chuo Yew Ting iD, Swee Kim Chan iD, Siew Teck Tie iD

Tropical Medicine & International Health · 2024-05 · 29 (5) · 434-445

DOI: 10.1111/tmi.13987 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Tropical Medicine & International Health, online erschienen am 12.03.2024. Verfasst von Ai Ling Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Antitubercular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Treatment interruption is associated with poor tuberculosis (TB) treatment outcomes and increased drug resistance. To address the issue, we aimed to investigate the characteristics, predictors and consequences of treatment interruption.

Methods

We conducted a retrospective cohort study by retrieving 4 years (2018–2021) of TB patients' records at 10 public health clinics in Sarawak, Malaysia. Adult patients (≥18 years) with drug‐susceptible TB were selected. Treatment interruption was defined as ≥2 weeks of cumulative interruption during treatment. The Chi‐square test, Mann–Whitney U test, Kaplan–Meier and Cox proportional hazards regression were used to analyse the data, with p < 0.05 being considered statistically significant.

Results

Out of 2953 eligible patients, 475 (16.1%) experienced TB treatment interruption. Interruptions were most frequent during the intensive phase (46.9%, n = 223), with the greatest risk within the first 4 weeks of treatment. The median time to interruption was 2 weeks in the intensive phase and the cumulative interruption probability at the end of the intensive phase was 12.9%. Notably, treatment interruption occurred during both intensive and continuation phases for 144 patients (30.3%), while the remaining 108 (22.7%) experienced interruptions only during the continuation phase with a median time to interruption of 16 weeks. Three predictors were identified to increase the risk of treatment interruption: adverse drug reaction (aHR = 8.53, 95% Cl: 6.73–10.82), smoking (aHR = 2.67, 95% Cl: 2.03–3.53) and illicit drug use (aHR = 1.88, 95% Cl: 1.03–3.45). Conversely, underlying diabetes was associated with a reduced likelihood of treatment interruption (aHR = 0.72, 95% Cl: 0.58–0.90). Treatment interruption led to significant differences in treatment restarts (62.3% vs. 0.7%), changes in medications (47.8% vs. 4.9%), prolonged treatment duration (247 days [IQR = 105] vs. 194 days [IQR = 44.3]) and lower successful outcomes (86.5% vs. 99.9%).

Conclusion

Understanding the temporal characteristics, predictors and negative consequences of treatment interruption can guide the development of time‐relevant approaches to mitigate the problem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsHumansRetrospective StudiesFemaleMaleAdultMalaysiaMiddle AgedTuberculosisYoung AdultCohort StudiesRisk FactorsTreatment OutcomeProportional Hazards ModelsTreatment InterruptionDrug Monitoring

Stichwörter der Autor:innen

Malaysiacharacteristicsconsequencespredictorstreatment interruptiontuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Department of Pharmacy, Sarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
  • Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Sarawak State Health, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.
  • Division of Respiratory Medicine, Department of Internal Medicine, Sarawak General Hospital, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia.

ORCID-Profile: Ai Ling Oh, Farida Islahudin, Chuo Yew Ting, Swee Kim Chan, Siew Teck Tie

Zitieren

APA

Oh, A. L., Makmor-Bakry, M., Islahudin, F., Ting, C. Y., Chan, S. K., & Tie, S. T. (2024). Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study. Tropical Medicine & International Health, 29(5), 434-445. https://doi.org/10.1111/tmi.13987

Vancouver

Oh AL, Makmor-Bakry M, Islahudin F, Ting CY, Chan SK, Tie ST. Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study. Tropical Medicine & International Health. 2024;29(5):434-445. doi:10.1111/tmi.13987

BibTeX
@article{Oh2024,
  author = {Oh, Ai Ling and Makmor-Bakry, Mohd and Islahudin, Farida and Ting, Chuo Yew and Chan, Swee Kim and Tie, Siew Teck},
  title = {Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study},
  journal = {Tropical Medicine & International Health},
  year = {2024},
  volume = {29},
  number = {5},
  pages = {434--445},
  doi = {10.1111/tmi.13987}
}
Kostenlos starten →